Author:
Ziegler S.,Nadal D.,Kreth H. W.,Schrod L.,Schöni M. H.,Wahn V.,Horneff G.,Holländer G. A.,Urbanek R.,Schuster A.,Götz M.,Birrer P.,Wildhaber J. H.,Oberwaldner B.,Bauer C.-P.,Innenmoser J.,Gruber W.,Nicola T.,Eber E.,Hartmann H.,Fanconi S.,Burger R.,Kachel W.,Paul K.,Hetzer R.
Publisher
Springer Berlin Heidelberg
Reference172 articles.
1. Hoibi N, Ciofu O, Jensen T et al. (1996) Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis. Pediatr Infect Dis J 15: 738–743
2. Jacobs RF, Schutze GE, Young RA, Kearns GL, James LP (1997) Antimicrobial agents. In: Long SS, Pickering LK, Prober CG (eds) Practice and principles of pediatric infectious diseases. Churchill Livingstone, New York, pp 1606–1662
3. Lebel MH, McCracken GH jr (1988) Aztreonam: Review of the clinical experience and potential uses in pediatrics. Pediatr Infect Dis J 7: 331
4. Mims CA, Playfair JHL, Roitt IM et al. (1993) Medical microbiology. Mosby, St. Louis, pp 351–3522
5. Nelson JD (1996) Pocket book of pediatric antimicrobial therapy. Williams and Wilkins, Baltimore